from the Nanoparticles-for-diagnosis dept.
Wendy Emanuel writes with a September 17, 2002 press release from Nanosphere Inc. announcing Nanosphere Inc. Awarded Two NIH Grants to Assess Genetic Risk Factors for Cancer and Hypercoagulation Disorders. The work to be financed by $1.5 million in NIH funds features the company's ultra sensitive detection platform using "nanoparticle probe technology in conjunction with a proprietary bio-molecular detection system".
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.